Northeast Financial Consultants’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,167
Closed -$242K 351
2022
Q2
$242K Buy
7,167
+11
+0.2% +$385 0.02% 285
2022
Q1
$250K Buy
7,156
+10
+0.1% +$342 0.01% 338
2021
Q4
$218K Sell
7,146
-1,444
-17% -$47K 0.01% 328
2021
Q3
$282K Sell
8,590
-3,980
-32% -$127K 0.02% 293
2021
Q2
$380K Buy
+12,570
New +$414K 0.03% 254

Other funds holding OGN

Northeast Financial Consultants's OGN Position: Q3 2022 in Review

Northeast Financial Consultants sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 7,167 shares — an estimated $242K sold.

Northeast Financial Consultants first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $380K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Northeast Financial Consultants reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Northeast Financial Consultants sold 7,167 Organon & Co shares in Q3 2022, an estimated $242K.
  • Northeast Financial Consultants first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Northeast Financial Consultants's Organon & Co position peaked at $380K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Northeast Financial Consultants's 13F filing for Q3 2022, filed 15 Nov 2022.